General Information of the Compound
| Compound ID |
CP0533057
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(3,4-dihydro-2H-quinolin-1-yl)-N-pyridazin-3-ylpropanamide
Show/Hide
|
||||||||||||||||||
| Formula |
C16H18N4O
|
||||||||||||||||||
| Molecular Weight |
282.347
|
||||||||||||||||||
| Canonical SMILES |
O=C(CCN1CCCc2ccccc12)Nc1cccnn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H18N4O/c21-16(18-15-8-3-10-17-19-15)9-12-20-11-4-6-13-5-1-2-7-14(13)20/h1-3,5,7-8,10H,4,6,9,11-12H2,(H,18,19,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
BFXWIESZWHPGNR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound